Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated adding D-cycloserine to transcranial direct current stimulation (tDCS) for depression. The study, including participants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: The University of New South Wales | Conditions: Major Depressive Disorder, Bipolar Disorder | Phase 2 | Status: COMPLETED